AACR: A 'tissue agnostic' indication for Retevmo? Lilly says it's possible with RET cancer win
10th April 2021 Uncategorised 0 AACR: A ’tissue agnostic’ indication for Retevmo? Lilly says it’s possible with RET cancer win
aliu
Sat, 04/10/2021 – 10:04
More: AACR: A 'tissue agnostic' indication for Retevmo? Lilly says it's possible with RET cancer win
Source: fierce
